RegenLab USA, Inc. (RGNA)

RegenLab USA will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$6.00 - $8.00

Shares Offered

2,500,000

Deal Size

$17.50M

RegenLab USA Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	157	-	-
Market Cap Growth	-	-	-
Enterprise Value	192	-	-

Financial Efficiency

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-4.11	-4.33	-4.25
Debt / EBITDA Ratio	11.27	201.98	5.02
Debt / FCF Ratio	14.30	-	25.93
Net Debt / Equity Ratio	-3.61	-4.13	-4.13
Net Debt / EBITDA Ratio	9.91	193.02	4.88
Net Debt / FCF Ratio	12.57	-	25.18
Quick Ratio	0.38	0.29	0.31
Interest Coverage	0.66	-3.11	4.47
Return on Assets (ROA)	-	-2.34%	5.21%
Return on Invested Capital (ROIC)	-	2.82%	11.34%
Return on Capital Employed (ROCE)	-7.02%	-3.01%	14.31%